Clinical Trial Update: Use of Chinese Herbal Formula Shu Yu Wan in Lung Cancer Patients [NA]

View source ↗

Summary

A clinical trial evaluating Shu Yu Wan, a Chinese herbal formula, for metastatic non-small cell lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Shu Yu Wan

Snippet

Sponsor: Lady Davis Institute | Conditions: Metastatic NSCLC | NA | Status: WITHDRAWN